Cargando…

Combined Effects of Obesity and Dyslipidaemia on the Prevalence of Diabetes Amongst Adults Aged ≥45 Years: Evidence from a Nationally Representative Cross-Sectional Study

Objectives: This study aimed to explore the combined effects of different types of obesity and dyslipidaemia on the prevalence of diabetes in middle-aged and elderly residents. Methods: Data were obtained from the 2015 China Health and Retirement Longitudinal Studydatabase, and 5023 valid participan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Simin, Sun, Donghan, Qian, Xiaoyi, Li, Li, Wu, Wenwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266151/ https://www.ncbi.nlm.nih.gov/pubmed/35805693 http://dx.doi.org/10.3390/ijerph19138036

Ejemplares similares

Trends in Prevalence of Dyslipidaemias and the Risk of Mortality in Lithuanian Urban Population Aged 45–64 in Relation to the Presence of the Dyslipidaemias and the Other Cardiovascular Risk Factors
por: Luksiene, Dalia, et al.
Publicado: (2014)

Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review
por: Alhyas, Layla, et al.
Publicado: (2011)

Associations between smoking and blood-group, and the risk of dyslipidaemia amongst French women
por: MacDonald, C. J., et al.
Publicado: (2021)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

Pex11a deficiency causes dyslipidaemia and obesity in mice
por: Chen, Congcong, et al.
Publicado: (2018)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity
por: Moraba, Mpho, et al.
Publicado: (2013)

Provincial heterogeneity in the management of care cascade for hypertension, diabetes, and dyslipidaemia in China: Analysis of nationally representative population-based survey
por: Zhao, Yang, et al.
Publicado: (2022)

Impact of Sociodemographic Characteristics, Lifestyle, and Obesity on Coexistence of Diabetes and Hypertension: A Structural Equation Model Analysis amongst Chinese Adults
por: Wu, Wenwen, et al.
Publicado: (2021)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica
por: Gordon, Lorenzo, et al.
Publicado: (2010)

The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population
por: Qian, Yun, et al.
Publicado: (2010)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia
por: Fiseha, Temesgen, et al.
Publicado: (2021)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

Prevalence of prehypertension in young military adults & its association with overweight & dyslipidaemia
por: Ray, Sougat, et al.
Publicado: (2011)

Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns
por: Olamoyegun, Michael Adeyemi, et al.
Publicado: (2016)

Global prevalence of dyslipidaemia in adult populations: a systematic review protocol
por: Mohamed-Yassin, Mohamed-Syarif, et al.
Publicado: (2021)

Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities
por: Masilela, Charity, et al.
Publicado: (2022)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Validity of self‐reported hypertension in India: Evidence from nationally representative survey of adult population over 45 years
por: Bhatia, Mrigesh, et al.
Publicado: (2022)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Prevalence of dyslipidaemia and risk factors in Chinese coal miners: a cross-sectional survey study
por: Fan, Ye, et al.
Publicado: (2017)

New susceptibility locus for obesity and dyslipidaemia on chromosome 3q22.3
por: Alshahid, Maie, et al.
Publicado: (2013)

The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
por: Aldini, Giancarlo, et al.
Publicado: (2011)

Association of SULT1A2 rs1059491 with obesity and dyslipidaemia in southern Chinese adults
por: Lv, Hai-Yan, et al.
Publicado: (2023)

Association between alcohol dietary pattern and prevalence of dyslipidaemia: WASEDA’S Health Study
por: Tanisawa, Kumpei, et al.
Publicado: (2022)

A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia
por: Mohamed-Yassin, Mohamed-Syarif, et al.
Publicado: (2023)

Prevalence and Numbers of Diabetes Patients with Elevated BMI in China: Evidence from a Nationally Representative Cross-Sectional Study
por: Wang, Yongjuan, et al.
Publicado: (2022)

National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15–69 years in Mongolia in 2019
por: Pengpid, Supa, et al.
Publicado: (2022)

Prevalence of Dyslipidaemia, Obesity and Vitamin d Insufficiency Among Patients Attending the Diabetic Clinic at Queen Elizabeth Central Hospital in Malawi
por: Katundu, Kondwani, et al.
Publicado: (2022)

Prevalence and associated factors of dyslipidaemia among university workers in Southeast Nigeria: a cross-sectional study
por: Okafor, Adaobi M., et al.
Publicado: (2021)

Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
por: Mallon, Patrick W. G
Publicado: (2006)

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011)

Adverse effects of the ‘Noakes’ diet on dyslipidaemia
por: Schamroth, C
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8vnq8h2i8o5q6cdk9jjvl3i4jn